GSK_Annual_Report_2021

Annual Report 2020-21 63 b) Performance bonus is paid as a percentage of salary, based on certain pre-agreed performance parameters. c) The above figures do not include provision for encashable leave, gratuity and premium paid for health insurance. d) There is no separate provision for payment of severance fees. e) None of the Directors other than those listed above are paid remuneration. f) None of the other Non-Executive Directors hold any shares of the Company except Ms. R. S. Karnad who holds 600 equity shares of the Company. 5. CORPORATE SOCIAL RESPONSIBILITY (CSR) COMMITTEE In compliance with the provisions of Section 135 of the Companies Act, 2013, the composition of the Corporate Social Responsibility Committee is as follows: Name of the Member Designation Category of Directorship Mr. A.N. Roy Chairman Non-Executive & Independent Dr. (Ms.) S. Maheshwari Member Non-Executive & Independent Mr. S. Venkatesh Member Managing Director During the year under review, the Committee met on 22 January 2021 and all the members attended the meeting. Please refer to the Board’s Report and its annexures for details regarding CSR activities. 6. STAKEHOLDERS RELATIONSHIP COMMITTEE In compliance with the provisions of Section 178 of the Companies Act, 2013 and clause 20 of the Listing Obligations & Disclosures Regulations, 2015, the composition of the Investors / Shareholders Grievance Committee is as follows: Name of the Member Designation Category of Directorship Ms. R. S. Karnad Chairman Non-Executive Mr. P. V. Bhide Member Non-Executive & Independent Mr. S. Venkatesh Member Managing Director During the year under review, the Committee met on 5 February 2021 and all the members attended the meeting. Name, designation and address of the Compliance Officer: Mr. Ajay Nadkarni Company Secretary Dr. Annie Besant Road Worli, Mumbai - 400 030 Phone: (022) 2495 9433 Fax: (022) 2498 1526 Email ID: ajay.a.nadkarni@gsk.com The complaints received during the year under review are as follows: Sr. No Particulars No. of Complaint 1 At the beginning of the year 00 2 Received during the year 58 3 Resolved during the year 58 4 Pending at the end of the year 00 During the year under review, the above complaints regarding non-receipt of shares sent for transfer, demat queries and non-receipt of dividend warrants and annual reports were received from the shareholders, all of them were resolved. The Company had no transfers pending at the close of the financial year.